UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 651

Sortiert nach

Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals

Orphanet journal of rare diseases, 2022-10, Vol.17 (1), p.1-398, Article 398

2022

Volltextzugriff (PDF)

Evolutionary Thought in Psychology: A Brief History

Plotkin, Henry

1, 2008

Volltextzugriff (PDF)

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

The New England journal of medicine, 1998-10, Vol.339 (14), p.947-952

1998

Volltextzugriff (PDF)

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

The journal of clinical endocrinology and metabolism, 2003-03, Vol.88 (3), p.986-992

2003

Volltextzugriff (PDF)

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry

Osteoporosis international, 2008-10, Vol.19 (10), p.1369-1378

2008

Volltextzugriff (PDF)

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

The journal of clinical endocrinology and metabolism, 2000-05, Vol.85 (5), p.1846-1850

2000

Volltextzugriff (PDF)

Graphic Medicine-The Best of 2019

JAMA : the journal of the American Medical Association, 2019-12, Vol.322 (24), p.2368

2019

Volltextzugriff (PDF)

The Gene Responsible for Pseudohypoparathyroidism Type Ib Is Paternally Imprinted and Maps in Four Unrelated Kindreds to Chromosome 20q13.3

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.11798-11803

1998

Volltextzugriff (PDF)

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Bone (New York, N.Y.), 1998-06, Vol.22 (6), p.683-690

1998

Volltextzugriff (PDF)

Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults

Bone (New York, N.Y.), 2012-05, Vol.50, p.S39-S39

2012

Volltextzugriff (PDF)

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

Bone, 2008-12, Vol.43 (6), p.1115-1121

2008

Volltextzugriff (PDF)

Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004

Neuromuscular disorders : NMD, 2005-01, Vol.15 (1), p.80-85

2005

Volltextzugriff (PDF)

Stuart H. Perry's contributions to meteorite collection and research, 1927-1957

Meteoritics & planetary science, 2009-08, Vol.44 (8), p.1161-1177

2009

Volltextzugriff (PDF)

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-10, Vol.382 (9902), p.1424-1432

2013

Volltextzugriff (PDF)

The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy

Journal of bone and mineral research, 2010-03, Vol.25 (3), p.520-526

2010

Volltextzugriff (PDF)

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

The Journal of clinical investigation, 2002-11, Vol.110 (9), p.1293-1299

2002

Volltextzugriff (PDF)

Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans : Potential as an anabolic therapy for osteoporosis

The journal of clinical endocrinology and metabolism, 1998-08, Vol.83 (8), p.2786-2791

1998

Volltextzugriff (PDF)

We-Intentionality: An Essential Element in Understanding Human Culture?

Perspectives in biology and medicine, 2003, Vol.46 (2), p.283-296

Plotkin, H. C. (Henry C.)

2003

Volltextzugriff (PDF)

Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy

Journal of bone and mineral research, 2003-04, Vol.18 (4), p.610-614

2003

Volltextzugriff (PDF)

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4569-4575

2003

Volltextzugriff (PDF)

Le Darwin de Hopkins: déchiffrage contextuel

LISA (Caen, France), 2009-05, Vol.7, p.476-489

Plotkin, Cary H

2009

Volltextzugriff (PDF)

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV

Pediatrics (Evanston), 2003-05, Vol.111 (5 Pt 1), p.1030

2003

Volltextzugriff (PDF)

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Journal of bone and mineral research, 2000-09, Vol.15 (9), p.1650-1658

2000

Volltextzugriff (PDF)

Two Questions About Osteogenesis Imperfecta

Journal of pediatric orthopaedics, 2006-01, Vol.26 (1), p.148-149

Plotkin, Horacio

2006

Volltextzugriff (PDF)

Non-genetic transmission of information: Candidate cognitive processes and the evolution of culture

Behavioural processes, 1995-12, Vol.35 (1), p.207-213

Plotkin, H.C.

1995

Volltextzugriff (PDF)

1 – 25 von 651

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(567)
Mit Volltextzugriff
(498)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(358)
Life Sciences & Biomedicine
(308)
Humans
(291)
Male
(153)
Female
(150)
Biological And Medical Sciences
(108)
Animals
(87)
Adult
(83)
Medical Sciences
(78)
Middle Aged
(77)
Child
(52)
Aged
(48)
Immunology
(47)
Infectious Diseases
(47)
Child, Preschool
(46)
Adolescent
(45)
Microbiology
(45)
Vaccination
(40)
Fundamental And Applied Biological Sciences. Psychology
(37)
Infant
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals

Evolutionary Thought in Psychology: A Brief History

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

Graphic Medicine-The Best of 2019

The Gene Responsible for Pseudohypoparathyroidism Type Ib Is Paternally Imprinted and Maps in Four Unrelated Kindreds to Chromosome 20q13.3

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004

Stuart H. Perry's contributions to meteorite collection and research, 1927-1957

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans : Potential as an anabolic therapy for osteoporosis

We-Intentionality: An Essential Element in Understanding Human Culture?

Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

Le Darwin de Hopkins: déchiffrage contextuel

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Two Questions About Osteogenesis Imperfecta

Non-genetic transmission of information: Candidate cognitive processes and the evolution of culture

Suchergebnisse filtern